{"id":52638,"date":"2023-01-06T16:02:22","date_gmt":"2023-01-06T15:02:22","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/insights-on-the-long-read-sequencing-global-market-to-2031-rise-in-utilization-of-sequence-analysis-methodologies-drives-growth-researchandmarkets-com\/"},"modified":"2023-01-06T16:02:22","modified_gmt":"2023-01-06T15:02:22","slug":"insights-on-the-long-read-sequencing-global-market-to-2031-rise-in-utilization-of-sequence-analysis-methodologies-drives-growth-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/insights-on-the-long-read-sequencing-global-market-to-2031-rise-in-utilization-of-sequence-analysis-methodologies-drives-growth-researchandmarkets-com\/","title":{"rendered":"Insights on the Long Read Sequencing Global Market to 2031 – Rise in Utilization of Sequence Analysis Methodologies Drives Growth – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Long Read Sequencing Market By Techniques, By Product, By Application, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nAccording to this report the long read sequencing market was valued at $603.48 million in 2021, and is estimated to reach $4.5 billion by 2031, growing at a CAGR of 22.3% from 2022 to 2031.\n<\/p>\n

\nLong-read sequencing is a class of DNA sequencing technique and is also known the third-generation sequencing. It aids in overcoming and coping with throughput, scope, and accuracy application limits in genomics. In comparison to short-read sequencing, it has a variety of benefits such as short-read sequencing can only create up to 600 bases of DNA, while as long read sequencing technology may produce reads of more than 10,000 bases.\n<\/p>\n

\nExtensive application of this technological environment is expected to result in an improvement in comprehension of evolution of pathogens, cancer, genetic variety, and drug resistance in intricate sections of genome that are crucial for clinical care.\n<\/p>\n

\nMajor factors that drive growth of the global long read sequencing market include rise in utilization of sequence analysis methodologies and surge in demand for genome mapping program. In addition, increase in investments by key players toward R&D related to long-read sequencing technologies and rise in prevalence of genetic disorders and chronic diseases such as cancer further propel the market growth.\n<\/p>\n

\nHowever, lack of skilled professionals, and ethical and legal limitations are expected to restrain growth of the long-read sequencing market during the forecast period. In addition, nanopore sequencer has a lower read accuracy when compared to short read sequencers, which further hampers growth of the market. Conversely, use of cloud computing as a potential data management service and high growth potential in untapped emerging countries are anticipated to provide lucrative opportunities among the market players.\n<\/p>\n

\nKey Benefits<\/strong>\n<\/p>\n